Citation Impact
Citing Papers
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
1996
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Immunization of pediatric solid‐organ transplantation candidates: Immunizations in transplant candidates
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Cancer burden in the year 2000. The global picture
2001 Standout
Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke
2002
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay
1991 StandoutNobel
Global Cancer Statistics, 2002
2005 Standout
Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease
2001
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS
1989 StandoutNobel
Distribution and function of prostanoid receptors: studies from knockout mice
2000
The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia
1995
Fructose‐1,6‐diphosphate attenuates prostaglandin E2 production and cyclo‐oxygenase‐2 expression in UVB‐irradiated HaCaT keratinocytes
2002
Antibody to Human Immunodeficiency Virus (HIV) and Suboptimal Response to Hepatitis B Vaccination
1988
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
1989 StandoutNobel
A Vaccine Consisting of RecombinantBorrelia burgdorferiOuter-Surface Protein A to Prevent Lyme Disease
1998
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Lessons from Hereditary Colorectal Cancer
1996 Standout
Potential Inhibitors of Tobacco Carcinogenesisa
1993
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ
2000 StandoutNatureNobel
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
1989 StandoutNobel
Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus–Infected Patients: A Double‐Blind, Randomized, Placebo‐Controlled Trial
2003
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan
1989 StandoutNobel
Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2
2000 Standout
Mechanisms of smoking-related lung and pancreatic adenocarcinoma development
2002
Inflammation and cancer: back to Virchow?
2001 Standout
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
1996 Standout
An Assessment of Clinically Useful Measures of the Consequences of Treatment
1988
Response to HBV vaccination in patients with severe liver disease
1992
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
1995 StandoutNature
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.
1991
Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions☆
1999
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
1990 StandoutNobel
Development of novel therapeutic strategies that target HIF-1
2006 StandoutNobel
Decay characteristics of HIV-1-infected compartments during combination therapy
1997 StandoutNature
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Impaired response to hepatitis B vaccine in HIV infected children
1992
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Hepatitis C antibody and chronic liver disease in haemophilia
1990 StandoutNobel
Analysis of Processing and Polyadenylation Signals of the Hepatitis B Virus Surface Antigen Gene by Using Simian Virus 40-Hepatitis B Virus Chimeric Plasmids
1983
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS
1984 StandoutScienceNobel
The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay.
1995 StandoutNobel
Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.
2003 StandoutNobel
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
1989 StandoutScienceNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src
1983 StandoutNobel
Hepatitis B vaccination for patients with chronic renal failure
2004
The Prevention of Hepatitis B with Vaccine
1982
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
The hepatitis B virus
1985 Nature
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons
1996
Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids.
1983
Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells.
1983
Synthesis of hepatitis B surface and core antigens in E. coli
1981 Nature
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
1991 Standout
Expression of human immunoglobulin E ε chain cDNA inE.coli
1983 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene
1986 StandoutNobel
Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
2008
RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: I, MEDICAL STAFF
1981
Early events in hepatitis C virus infection of chimpanzees.
1990 StandoutNobel
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Correlates of Protection Induced by Vaccination
2010 Standout
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1
1994 StandoutNobel
Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
1993
Works of Edith Zang being referenced
Doses of Nicotine and Lung Carcinogens Delivered to Cigarette Smokers
2000
A study of tobacco carcinogenesis. LI. Relative potencies of tobacco-specific N-nitrosamines as inducers of lung tumours in AJ mice
1993
Race and Sex Differences in Lung Cancer Risk Associated with Cigarette Smoking
1993
Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers
1992
Hepatitis B Vaccine in Medical Staff of Hemodialysis Units
1982
Hepatitis B Vaccine in Patients Receiving Hemodialysis
1984
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
1995
A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report
1981
The immune response of healthy adults to a reduced dose of hepatitis B vaccine
1981
Hepatitis B Vaccine
1980